Valeant Pharma (VRX) Pearson Said to Have Sold 5M Shares - CNBC
CNBC Scott Wapner reports Valeant Pharma (NYSE: VRX) Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m.
Seems $VRX CEO Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m!
— Scott Wapner (@ScottWapnerCNBC) July 13, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
- SpaceX short interest at 5-7% of float - S3 Partners
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
Create E-mail Alert Related Categories
Insider Trades, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share